FDA quietly pushes back deadline on electric shock ban

The FDA has extended the deadline for a ban on electric shock devices used for medical treatment, sparking debate over patient safety and regulatory oversight. This move comes amid growing concerns about the efficacy and ethical implications of such devices, which have been criticized for causing harm without significant therapeutic benefits. The delay likely reflects ongoing scrutiny and discussions about alternative, more effective treatments, emphasizing the importance of patient-centered care and evidence-based medicine in regulatory decisions.